Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. For example, while the average cost of the drug development pipeline has tripled ...

An exciting opportunity for a business development expert to shape the future of the PHG Foundation, help capitalise on its unique value and continue the mission of making science work for health. PHG ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

The optimism is not unfounded. In specific, well-defined clinical scenarios, polygenic scores are beginning to demonstrate some tangible utility. For cardiovascular disease, MI-GENES, a 10-year follow ...

With the current pandemic of bird flu – avian influenza – there is a growing concern around diseases spilling over from animals to humans. The COVID-19 pandemic highlighted the devastating impact such ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

Widely regarded as a founder of cell free DNA (cfDNA) technology, Professor Dennis Lo is now pioneering investigation into the emerging science of fragmentomics. If you were at were at our recent ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

The virtual launch this month of the Africa Pathogen Genomics Initiative (Africa PGI) marked a ground-breaking initiative to tackle infectious disease in Africa. Led by the African Union Commission ...

The UK government has launched a new alliance to sequence the genomes of SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Backed by a £20 million investment, the COVID-19 Genomics ...